Nektar Therapeutics
NKTR
#5783
Rank
S$1.65 B
Marketcap
S$48.44
Share price
-0.12%
Change (1 day)
-35.85%
Change (1 year)

Nektar Therapeutics (NKTR) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : S$0.24 Billion

According to Nektar Therapeutics 's latest financial reports the company's total liabilities are S$0.24 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nektar Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$0.35 B-23.51%
2022-12-31S$0.46 B-22.07%
2021-12-31S$0.59 B-3.08%
2020-12-31S$0.61 B-20.83%
2019-12-31S$0.77 B30.48%
2018-12-31S$0.59 B4.95%
2017-12-31S$0.56 B-19.06%
2016-12-31S$0.69 B-0.07%
2015-12-31S$0.69 B30.01%
2014-12-31S$0.53 B-19.4%
2013-12-31S$0.66 B20.53%
2012-12-31S$0.55 B4.14%
2011-12-31S$0.52 B-4.56%
2010-12-31S$0.55 B-16.51%
2009-12-31S$0.66 B25.41%
2008-12-31S$0.52 B-27.92%
2007-12-31S$0.73 B-11.44%
2006-12-31S$0.82 B-6.28%
2005-12-31S$0.88 B95.51%
2004-12-31S$0.45 B-41.11%
2003-12-31S$0.76 B10.83%
2002-12-31S$0.69 B-5.57%
2001-12-31S$0.73 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
S$148.59 B 60,259.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$148.26 B 60,126.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$107.63 B 43,622.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S$17.45 B 6,989.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$112.59 B 45,636.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$83.93 B 33,993.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
S$54.45 M-77.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
S$3.21 B 1,205.44%๐Ÿ‡ฎ๐Ÿ‡ช Ireland